Non-steroidal Anti-inflammatory Drug Increases Liver Damage In Mice Carrying Mutant Human Gene
Thu, 16 Nov 2006 04:00 AM EST
... Research performed at Washington University School of Medicine in St. Louis sheds light on the mechanisms that contribute to liver disease in alpha-1-AT deficiency patients. People with alpha-1-deficiency have a genetic mutation that can lead to emphysema at an early age and to liver damage. Using an experimental mouse model of the disorder, the researchers investigated the effects of a non-steroidal anti-inflammatory drug on liver injury. ...
Related Topics
- Genes and Gene Therapy
- Liver Disease
- Aging Skin
- Inflammatory Bowel Disease
- Liver Cancer
- Pelvic Inflammatory Disease
- Anti-Inflammatory Diets
- Anti-inflammatory Medications
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Liver Biopsy
- Meloxicam
- Atomoxetine
- Liver damage
- Human Papilloma Virus
- Damage to organs (such as the kidneys, brain, liver, and intestines)
- Cloning
- Growth Hormones
- Wrinkles
- Growth Hormone
- Human Papillomavirus

Not Signed In -

